PRIMO BRANDS CORP (PRMB)

NYSEConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-10-23

$19.69-2.23%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge PRIMO BRANDS CORP’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-1.2%

+10% or more+5%0%−5%−10% or less

1.49 → 1.47 EPS · FY ending Dec 31, 2027 · 7 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 7 to 7; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	1.6B
EPS	—	0.315
Annual ending 2026-12-31
Revenue	—	6.84B
EPS	—	1.351
Annual ending 2027-12-31
Revenue	—	7.08B
EPS	—	1.473

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Maintain dividend per share at $0.12	A supporting condition in PRIMO BRANDS CORP's published investment case. The stated target is Dividend per share >= $0.12.	Intact	Dividend per share falls below $0.12 in 2026-Q1	Dividend per share: $0.12 per share FY2026-Q2; GAAP. Published target: Dividend per share >= $0.12. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Aug 5, 20260.12 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: e45cac21-e95b-4b4a-8da3-5b1700cf6bb6. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Dividend per share was $0.10 in 2025-Q2 and increased to $0.12 by 2026-Q1. Cash dividends totaled $43.5 million in 2026-Q2. Management has consistently maintained and modestly increased dividends, delivering on shareholder return commitments. Delivery assessment Oct 24, 2026
Generate free cash flow near $800 million	Free cash flow is strong near $800 million.	Intact	Free cash flow falls below $790 million in FY26	Free cash flow: $142.4M FY2026-Q2; GAAP. Published target: >=$790 million. Target period is not explicitly aligned with this observation. Source published Aug 5, 2026142,400,000 USD · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Deliver on raised Adjusted EBITDA guidance	It has a solid brand in health drinks and good management execution.	Intact	Adjusted EBITDA falls below the lower bound of guidance in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Adjusted EBITDA grew 5.0% year-over-year to $385.0 million in 2026-Q2 from $366.7 million in 2025-Q2. Management widened and then reaffirmed the 2026 Adjusted EBITDA guidance range at $1,465 million to $1,515 million. The trajectory shows delivering growth with margin expansion. Delivery assessment Oct 24, 2026
Maintain revenue growth near 3% annually	A primary condition in PRIMO BRANDS CORP's published investment case. The stated target is >=3% YoY.	Intact	YoY revenue growth falls below 3% in FY26	Revenue growth: 3.82% FY2026-Q2; GAAP. Published target: >=3% YoY. Target period is not explicitly aligned with this observation. Source published Aug 5, 20263.820588 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: e45cac21-e95b-4b4a-8da3-5b1700cf6bb6. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Net sales grew 3.8% year-over-year to $1.8 billion in 2026-Q2 from $1.7 billion in 2025-Q2. Management raised the full-year Net Sales growth outlook twice, from 1%-3% to 2%-4% for 2026. The trajectory is delivering with top-line growth driven by premium brands and Direct Delivery. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$1.47

$1.48 → $1.47 · observed estimates

FY2027 revenue$7.08B

$7.02B → $7.08B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$1.48	$7,017,045,927	7 / 7
2026-07-25	$1.48	$7,012,018,590	12 / 9
2026-07-26	$1.48	$7,012,018,590	12 / 9
2026-07-27	$1.48	$7,012,018,590	12 / 9
2026-07-28	$1.48	$7,017,045,927	7 / 7
2026-07-29	$1.48	$7,012,018,590	12 / 9
2026-07-30	$1.48	$7,012,018,590	12 / 9
2026-07-31	$1.48	$7,017,045,927	7 / 7
2026-08-01	$1.48	$7,017,045,927	7 / 7
2026-08-02	$1.48	$7,012,018,590	12 / 9
2026-08-03	$1.48	$7,017,045,927	7 / 7
2026-08-04	$1.48	$7,017,045,927	7 / 7
2026-08-05	$1.48	$7,012,018,590	12 / 9
2026-08-06	$1.48	$7,012,018,590	12 / 9
2026-08-07	$1.49	$7,059,867,893	7 / 7
2026-08-08	$1.49	$7,065,146,450	12 / 9
2026-08-09	$1.49	$7,065,146,450	12 / 9
2026-08-10	$1.49	$7,065,146,450	12 / 9
2026-08-12	$1.49	$7,078,116,850	12 / 9
2026-08-13	$1.49	$7,059,867,893	7 / 7
2026-08-14	$1.49	$7,059,867,893	7 / 7
2026-08-15	$1.49	$7,059,867,893	7 / 7
2026-08-16	$1.49	$7,059,867,893	7 / 7
2026-08-17	$1.49	$7,059,867,893	7 / 7
2026-08-18	$1.49	$7,059,867,893	7 / 7
2026-08-19	$1.49	$7,059,867,893	7 / 7
2026-08-20	$1.49	$7,084,553,142	7 / 7
2026-08-21	$1.49	$7,084,553,142	7 / 7
2026-08-22	$1.49	$7,084,553,142	7 / 7
2026-08-23	$1.49	$7,084,553,142	7 / 7
2026-08-24	$1.49	$7,084,553,142	7 / 7
2026-08-25	$1.49	$7,084,553,142	7 / 7
2026-08-26	$1.49	$7,084,553,142	7 / 7
2026-08-27	$1.49	$7,084,553,142	7 / 7
2026-08-28	$1.49	$7,084,553,142	7 / 7
2026-08-29	$1.49	$7,084,553,142	7 / 7
2026-08-30	$1.49	$7,084,553,142	7 / 7
2026-08-31	$1.49	$7,084,553,142	7 / 7
2026-09-01	$1.49	$7,084,553,142	7 / 7
2026-09-02	$1.49	$7,084,553,142	7 / 7
2026-09-03	$1.49	$7,084,553,142	7 / 7
2026-09-04	$1.49	$7,084,553,142	7 / 7
2026-09-05	$1.49	$7,084,553,142	7 / 7
2026-09-06	$1.49	$7,084,553,142	7 / 7
2026-09-07	$1.49	$7,084,553,142	7 / 7
2026-09-08	$1.49	$7,084,553,142	7 / 7
2026-09-09	$1.49	$7,084,553,142	7 / 7
2026-09-10	$1.49	$7,084,553,142	7 / 7
2026-09-11	$1.49	$7,084,553,142	7 / 7
2026-09-12	$1.49	$7,084,553,142	7 / 7
2026-09-13	$1.49	$7,084,553,142	7 / 7
2026-09-14	$1.49	$7,084,553,142	7 / 7
2026-09-15	$1.49	$7,084,553,142	7 / 7
2026-09-16	$1.49	$7,084,553,142	7 / 7
2026-09-17	$1.49	$7,084,553,142	7 / 7
2026-09-18	$1.49	$7,084,553,142	7 / 7
2026-09-19	$1.49	$7,084,553,142	7 / 7
2026-09-20	$1.49	$7,084,553,142	7 / 7
2026-09-21	$1.49	$7,084,553,142	7 / 7
2026-09-22	$1.49	$7,084,553,142	7 / 7
2026-09-23	$1.49	$7,084,553,142	7 / 7
2026-09-24	$1.49	$7,084,553,142	7 / 7
2026-09-25	$1.49	$7,084,553,142	7 / 7
2026-09-26	$1.49	$7,084,553,142	7 / 7
2026-09-27	$1.49	$7,084,553,142	7 / 7
2026-09-28	$1.49	$7,084,553,142	7 / 7
2026-09-29	$1.49	$7,084,553,142	7 / 7
2026-09-30	$1.49	$7,084,553,142	7 / 7
2026-10-01	$1.49	$7,084,553,142	7 / 7
2026-10-02	$1.49	$7,084,553,142	7 / 7
2026-10-03	$1.49	$7,084,553,142	7 / 7
2026-10-04	$1.49	$7,084,553,142	7 / 7
2026-10-05	$1.49	$7,084,553,142	7 / 7
2026-10-06	$1.49	$7,082,994,960	7 / 7
2026-10-07	$1.49	$7,082,994,960	7 / 7
2026-10-08	$1.49	$7,082,994,960	7 / 7
2026-10-09	$1.49	$7,082,994,960	7 / 7
2026-10-10	$1.49	$7,082,994,960	7 / 7
2026-10-11	$1.48	$7,082,994,960	7 / 7
2026-10-12	$1.48	$7,082,994,960	7 / 7
2026-10-13	$1.48	$7,082,994,960	7 / 7
2026-10-14	$1.48	$7,082,994,960	7 / 7
2026-10-15	$1.48	$7,082,994,960	7 / 7
2026-10-16	$1.48	$7,082,994,960	7 / 7
2026-10-17	$1.48	$7,082,994,960	7 / 7
2026-10-18	$1.49	$7,082,994,960	7 / 7
2026-10-19	$1.49	$7,082,994,960	7 / 7
2026-10-20	$1.48	$7,075,994,960	7 / 7
2026-10-21	$1.48	$7,075,994,960	7 / 7
2026-10-22	$1.48	$7,075,994,960	7 / 7
2026-10-23	$1.48	$7,075,994,960	7 / 7
2026-10-24	$1.47	$7,075,994,960	7 / 7

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	11	2
2026-06-01	10	2
2026-07-01	10	2
2026-08-01	10	2
2026-09-01	10	2
2026-10-01	10	2

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 10 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades1 maintains

Recent actions · Sep 25–Oct 24 · 1 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Deutsche BankOct 19 · prior Aug 6

$25.00 → $21.00-16.0%

BarclaysOct 16 · prior Aug 7

$29.00 → $26.00-10.3%

$0$15.95$31.90

0 raises · 2 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Maintain dividend per share at $0.12Dividend per share: $0.12 per share
Generate free cash flow near $800 millionFree cash flow: $142.4M
Deliver on raised Adjusted EBITDA guidanceDirect metric needs a verified mapping
Maintain revenue growth near 3% annuallyRevenue growth: 3.82%

Next proof point

Nov 5, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.3%Typical daily move · historical

Downside history

-36.2%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

PRIMO BRANDS CORP outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

PRMB is a consumer staples company with a growth-and-execution thesis, rather than a turnaround. The thesis is intact: recent financial performance is strong and earnings quality is robust, but management has been volatile and overall risk is elevated.

What's priced into PRIMO BRANDS CORP

Valuation is expensive versus peers, with a peer premium of 1.0. The expectations gap is negative, suggesting the market’s assumptions are somewhat ahead of the model’s expectations, though the evidence labels pricing as justified and fragility as low.

What the fundamentals likely do

Near term, sales and adjusted EBITDA growth are supported by premium brands and Direct Delivery, and management has raised and reaffirmed its 2026 outlook. The miss risk is described as low, but peer misses and a deep miss in PRMB’s recent history remain cautions; a guidance cut would be a meaningful setback.

What PRIMO BRANDS CORP hinges on

Over the next few quarters, the thesis depends on continued sales growth, margin expansion, and management delivering on reaffirmed guidance. Weakening jobs data could add pressure to cyclical names, while continued strong results and guidance from sector peers could support sector momentum.